Search

Displaying results 7251 - 7260 of 10000 in total
  1. Drug

    Trichosporon cutaneum

    go.drugbank.com/drugs/DB10974
    Approved

    Trichosporon cutaneum allergenic extract is used in allergenic testing.

  2. Drug

    Fusarium graminearum

    go.drugbank.com/drugs/DB13907
    Approved

    Fusarium graminearum allergenic extract is used in allergenic testing.

  3. Drug

    Rainbow trout

    go.drugbank.com/drugs/DB15540
    Approved

    Rainbow trout allergenic extract is used in allergenic testing.

  4. Drug

    Atlantic mackerel

    go.drugbank.com/drugs/DB15542
    Approved

    Atlantic mackerel allergenic extract is used in allergenic testing.

  5. Drug

    Atlantic halibut

    go.drugbank.com/drugs/DB15549
    Approved

    Atlantic halibut allergenic extract is used in allergenic testing.

  6. Drug

    Mocetinostat

    go.drugbank.com/drugs/DB11830
    Investigational

    Mocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others.

  7. Drug

    Resolvin E1

    go.drugbank.com/drugs/DB13105
    Investigational

    Resolvin E1 (RX 10001) is under investigation in clinical trial NCT00941018 (Single and Multiple Ascending Oral Dose Study of Resolvin E1 in Healthy Volunteers).

  8. Drug

    Amuvatinib

    go.drugbank.com/drugs/DB12742
    Investigational

    Amuvatinib has been used in trials studying the treatment of Solid Tumors and Small Cell Lung Carcinoma. … Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA repair in cancer cells.

    Synonyms: 1-Piperazinecarbothioamide, N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro(3,2-d)pyrimidin-4-yl-, 4-[1]Benzofuro[3,2-D]Pyrimidin-4-Yl-N-(1,3-Benzodioxol-5-Ylmethyl)Piperazine-1-Carbothioamide
  9. Drug

    Fenspiride

    go.drugbank.com/drugs/DB08979
    Investigational

    Fenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases. … It is approved for use in Russia for the treatment of acute and chronic inflammatory diseases of ENT organs and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis

  10. Drug

    POT-4

    go.drugbank.com/drugs/DB06056
    Investigational

    The investigational drug was under investigation in clinical trial NCT00473928 (Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD) (ASaP)).